Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Plaque Psoriasis Interventions: Drug: ORKA-001; Other: Placebo Sponsors: Oruka Therapeutics, Inc. Recruiting Conditions: Plaque Psoriasis Interventions: Drug: ORKA-001; Other: Placebo Sponsors: Oruka Therapeutics, Inc....

Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Influenza Interventions: Biological: Recombinant Influenza vaccine candidate; Biological: Commercial Influenza vaccine Sponsors: Aramis Biotechnologies Inc. Not yet recruiting Conditions: Influenza Interventions: Biological: Recombinant Influenza vaccine...

Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome in the European Union (LEAP-EU)

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Alagille Syndrome Interventions: Drug: Livmarli Oral Product Sponsors: Mirum Pharmaceuticals, Inc. Recruiting Conditions: Alagille Syndrome Interventions: Drug: Livmarli Oral Product Sponsors: Mirum Pharmaceuticals, Inc....

Toripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Oropharyngeal Cancer Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors: University of Chicago Not yet recruiting Conditions: Oropharyngeal Cancer Interventions: Drug: Toripalimab; Drug: Carboplatin; Drug: Paclitaxel Sponsors:...

To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants

by palligoelme@gmail.com | Dec 18, 2025 | Clinical Trials

​ Conditions: Healthy Volunteers Interventions: Drug: Mirdametinib; Drug: Mirdametinib and Carbamazepine Sponsors: SpringWorks Therapeutics, Inc. Not yet recruiting Conditions: Healthy Volunteers Interventions: Drug: Mirdametinib; Drug: Mirdametinib and Carbamazepine...